These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 11708278)

  • 1. Metabolic alterations in HIV lipodystrophy. IAPAC sessions 2001, July 18-19, 2001 - Chicago.
    Kotler DP
    IAPAC Mon; 2001 Aug; 7(8):241-5. PubMed ID: 11708278
    [No Abstract]   [Full Text] [Related]  

  • 2. Body habitus changes in HIV-associated lipodystrophy syndrome (HIV-LS). IAPAC sessions 2001, July 18-19, 2001 - Chicago.
    Kingsley LA
    IAPAC Mon; 2001 Aug; 7(8):246-50. PubMed ID: 11708279
    [No Abstract]   [Full Text] [Related]  

  • 3. PI/NRTI "sparing" regimens for HIV infection. IAPAC sessions 2001, July 18-19, 2001 - Chicago.
    Cohen C
    IAPAC Mon; 2001 Aug; 7(8):254-60. PubMed ID: 11708281
    [No Abstract]   [Full Text] [Related]  

  • 4. The latest word on lipodystrophy and mitochondrial toxicity (and old words that still resound).
    Mascolini M
    IAPAC Mon; 2002 Jan; 8(1):14-32. PubMed ID: 11858198
    [No Abstract]   [Full Text] [Related]  

  • 5. Sustained benefits of metformin therapy on markers of cardiovascular risk in human immunodeficiency virus-infected patients with fat redistribution and insulin resistance.
    Hadigan C; Rabe J; Grinspoon S
    J Clin Endocrinol Metab; 2002 Oct; 87(10):4611-5. PubMed ID: 12364443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased PAI-1 and tPA antigen levels are reduced with metformin therapy in HIV-infected patients with fat redistribution and insulin resistance.
    Hadigan C; Meigs JB; Rabe J; D'Agostino RB; Wilson PW; Lipinska I; Tofler GH; Grinspoon SS;
    J Clin Endocrinol Metab; 2001 Feb; 86(2):939-43. PubMed ID: 11158071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Limitations and uncertainties of resistance testing: a review of "negative" trials. IAPAC sessions 2001, July 18-19, 2001 - Chicago.
    Sherer R;
    IAPAC Mon; 2001 Aug; 7(8):237-41. PubMed ID: 11708277
    [No Abstract]   [Full Text] [Related]  

  • 8. Fat, sugar and drugs on the French Riviera.
    Lands L
    GMHC Treat Issues; 1999 Mar; 13(3):9-11. PubMed ID: 11366205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular risk and body-fat abnormalities in HIV-infected adults.
    Grinspoon S; Carr A
    N Engl J Med; 2005 Jan; 352(1):48-62. PubMed ID: 15635112
    [No Abstract]   [Full Text] [Related]  

  • 10. Metabolic abnormalities in patients with HIV infection.
    Mulligan K
    J Int Assoc Physicians AIDS Care (Chic); 2003; 2(2):66-74. PubMed ID: 12961760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic complications in HIV infection. In search of underlying mechanisms.
    Johnson DL
    Adv Nurse Pract; 2002 Jul; 10(7):45-50, 76. PubMed ID: 12420551
    [No Abstract]   [Full Text] [Related]  

  • 12. How to manage metabolic complications of HIV therapy: what to do while we wait for answers.
    Currier JS
    AIDS Read; 2000 Mar; 10(3):162-9; discussion 171-4. PubMed ID: 10758016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized placebo-controlled trial of metformin for the treatment of HIV lipodystrophy.
    Kohli R; Shevitz A; Gorbach S; Wanke C
    HIV Med; 2007 Oct; 8(7):420-6. PubMed ID: 17760733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin resistance in the HIV-lipodystrophy syndrome.
    Grinspoon S
    Trends Endocrinol Metab; 2001 Nov; 12(9):413-9. PubMed ID: 11595544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New guidelines on metabolic complications of HIV and antiretroviral treatment.
    AIDS Treat News; 2002 Nov; (385):2. PubMed ID: 12492037
    [No Abstract]   [Full Text] [Related]  

  • 16. Metabolic complications of HIV-1 antiretroviral therapy: the lipodystrophy syndrome.
    Borderi M; Verucchi G; Tadolini M; Spinosa S; Fortunato L; Talò S; Chiodo F
    New Microbiol; 2001 Jul; 24(3):303-15. PubMed ID: 11497090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV-associated lipodystrophy.
    Mallon PW; Cooper DA; Carr A
    HIV Med; 2001 Jul; 2(3):166-73. PubMed ID: 11737397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects of rosiglitazone and metformin on postprandial lipemia in patients with HIV-lipodystrophy.
    van Wijk JP; Hoepelman AI; de Koning EJ; Dallinga-Thie G; Rabelink TJ; Cabezas MC
    Arterioscler Thromb Vasc Biol; 2011 Jan; 31(1):228-33. PubMed ID: 20947819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipodystrophy, insulin resistance, diabetes mellitus, dyslipidemia, and cardiovascular disease in human immunodeficiency virus infection.
    Tanwani LK; Mokshagundam SL
    South Med J; 2003 Feb; 96(2):180-8; quiz 189. PubMed ID: 12630645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update from the 3rd International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV.
    Cofrancesco J
    Hopkins HIV Rep; 2002 Jan; 14(1):6-7, 12. PubMed ID: 11851123
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.